Mapping iron in human heart tissue with synchrotron x-ray fluorescence microscopy and cardiovascular magnetic resonance by Michael J House et al.
House et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:80
http://jcmr-online.com/content/16/1/80RESEARCH Open AccessMapping iron in human heart tissue with
synchrotron x-ray fluorescence microscopy and
cardiovascular magnetic resonance
Michael J House1, Adam J Fleming1, Martin D de Jonge2, David Paterson2, Daryl L Howard2, John-Paul Carpenter3,4,
Dudley J Pennell3,4* and Tim G St Pierre1Abstract
Background: MRI assessment of cardiac iron is particularly important for assessing transfusion-dependent anaemia
patients. However, comparing the iron distribution from histology or bulk samples to MRI is not ideal. Non-destructive,
high-resolution imaging of post-mortem samples offers the ability to examine iron distributions across large samples
at resolutions closer to those used in MRI. The aim of this ex vivo case study was to compare synchrotron X-ray
fluorescence microscopy (XFM) elemental iron maps with magnetic resonance transverse relaxation rate maps of
cardiac tissue samples from an iron-loaded patient.
Methods: Two 5 mm thick slices of formalin fixed cardiac tissue from a Diamond Blackfan anaemia patient were
imaged in a 1.5 T MR scanner. R2 and R2* transverse relaxation rate maps were generated for both slices using RF pulse
recalled spin echo and gradient echo acquisition sequences. The tissue samples were then imaged at the Australian
Synchrotron on the X-ray Fluorescence Microscopy beamline using a focussed incident X-ray beam of 18.74 keV and
the Maia 384 detector. The event data were analyzed to produce elemental iron maps (uncalibrated) at 25 to 60
microns image resolution.
Results: The R2 and R2* maps and profiles for both samples showed very similar macro-scale spatial patterns
compared to the XFM iron distribution. Iron appeared to preferentially load into the lateral epicardium wall and there
was a strong gradient of decreasing iron, R2 and R2* from the epicardium to the endocardium in the lateral wall of the
left ventricle and to a lesser extent in the septum. On co-registered images XFM iron was more strongly correlated to
R2* (r = 0.86) than R2 (r = 0.79). There was a strong linear relationship between R2* and R2 (r = 0.87).
Conclusions: The close qualitative and quantitative agreement between the synchrotron XFM iron maps and MR
relaxometry maps indicates that iron is a significant determinant of R2 and R2* in these ex vivo samples. The R2 and R2*
maps of human heart tissue give information on the spatial distribution of tissue iron deposits.
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Quantitative cardiovascular magnetic resonance imaging
(CMR) techniques have been developed to non-invasively
assess iron loading in the heart. CMR assessment of
cardiac iron is particularly important for assessing
transfusion-dependent anaemia patients, who can accu-
mulate dangerous levels of iron in the heart that can
eventually lead to heart failure. Chelation therapy has
been successful in treating these patients, but directly
monitoring heart iron loading is difficult.
Historically iron distribution has been measured and
mapped using histological staining, which can provide
some detailed information on iron distribution across
small areas [1], but these stains are specific to the chem-
ical speciation of iron and only semi-quantitative. Bio-
chemical analysis of post-mortem heart samples suggests
that there is a gradient in iron concentration from the
epicardial to the endocardial layer [2,3]. However, these
bulk-sample techniques are relatively crude, destructive,
and lack detailed spatial resolution. Biopsies are invasive
and potentially unreliable because of the uneven distri-
bution of iron in the heart.
To overcome the limitations inherent in biopsied ma-
terial, quantitative CMR techniques have been developed
to assess iron loading in the heart. These non-invasive
techniques rely on measuring the proton transverse re-
laxation time or T2*. Typically a T2* image of a cross-
section through the heart is generated and a region of
interest in the septum selected to calculate an average
T2* value. A low value of T2* (less than 20 ms) indicates
iron overload in the heart tissue [4] and for patients with
T2* less than 10 ms the risk of heart failure is signifi-
cantly increased [5].
While the concentration of iron has a strong effect on
T2*, it is not the sole determinant as the distribution and
size of the iron deposits and susceptibility artefacts (e.g.
proximity of blood vessels) can affect the relaxation
time. The potential susceptibility artefacts in vivo limit
the reliable region of the heart that can be assessed
using T2* to the interventricular septum, a bridge of tis-
sue separating the left and right ventricles [6,7].
Determining how closely CMR measurements repre-
sent the actual iron distribution in the human heart has
been hindered by technical issues and artefacts associ-
ated with measuring the beating heart in vivo and a lack
of quantitative elemental data at sufficient spatial reso-
lution. CMR images are comprised of voxels, each voxel
representing a sample volume of about 4 mm3 (ex-vivo),
in comparison to the sample volumes of bulk biochem-
ical methods, which are typically 150 times larger.
Hence, relating CMR measurements to elemental ana-
lysis results, for example, is likely to be affected by par-
tial volume sampling bias. In principle these errors can
be minimised by making ex vivo CMR measurements onheart samples [3,8], but until recently obtaining elemen-
tal maps at a comparable resolution to CMR has been
difficult.
Elemental mapping techniques based on synchrotron
XFM have successfully imaged iron and other metals in
human and rat brain tissue at resolutions approaching
one micron [9-14]. We hypothesised that a similar elem-
ental mapping technique applied to the heart, combined
with ex vivo quantitative CMR measurements, would
allow a much closer comparison and better understand-
ing of the relationship between R2*, R2 and iron in the
heart. We now present a single case history examination
comparing iron maps generated by synchrotron XFM
and quantitative CMR measurements.
Methods
Case history
The heart tissue for this case study came from a larger
study of 12 patients investigating the amount and distri-
bution of iron in the heart [8]. The 22 year old male pa-
tient had Diamond Blackfan anaemia and died of cardiac
failure and pneumonia. He was transfusion dependent
and received chelation therapy from the age of 10, but
compliance was poor. His mean left ventricular iron
concentration was 3.91 mg/g dry weight [8]. The study
protocol was approved by all local research ethics com-
mittees, and local consent was obtained.
Sample preparation
The heart was fixed in 10% neutral buffered formalin.
Two slices of 5 mm thickness were cut in the ventricular
short axis. The smaller slice was taken from a location
closer to the heart apex and was labelled slice 7968. The
larger slice was taken from a location closer to the mid-
section and was labelled slice 7970.
CMR and analysis protocols
All CMR measurements were made on Siemens 1.5 T
Avanto scanner (Siemens Medical Systems, Erlangen,
Germany) using a phased-array body coil. R2 measure-
ments were made with the tissue samples in air. A single
spin echo sequence was used to acquire R2 data with
seven echo-times between 6 and 30 ms, a TR of 750 ms,
a flip angle of 90 degrees, and two signal averages. The
field of view was 90 by 120 mm and the matrix was 192
by 256 pixels. For R2* measurements the heart slices
were placed between Perspex plates and immersed in ul-
trapure water in such a way as to minimise the presence
of bubbles. The temperature of the water containing the
samples was 21.5°C. A multi-echo gradient echo se-
quence was used to acquire R2* data with eight echo-
times (TE) between 2.47 and 18.95 ms, a repetition time
(TR) of 22 ms, a flip angle of 35 degrees, and four signal
averages. The field of view was 130 by 130 mm
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4 mm thickness were acquired parallel to the top and
bottom surfaces of the tissue. Using high-resolution
localiser images the slices were positioned such that the
majority of the slice was within the margin of the tissue.
R2 and R2* values were calculated for each voxel using
the CMR Analysis Calculator plug-in for ImageJ (v1.42).
The software fits a monoexponential decay function of
the form,
S TEð Þ ¼ S 0ð Þe−R2TE; ð1Þ
to the data, where S(0) is the initial amplitude. Voxels
were excluded where the goodness of fit parameter (R2)
was less than 0.9. Maps of R2 were filtered to reduce
noise by using a median filter with a radius of two
pixels.
Synchrotron sample preparation and imaging
Excess formalin was removed from the samples before
heat-sealing each slice inside 30 micron thick polypro-
pylene film (Good Fellow PP301300) approximately
72 hours before the synchrotron experiment. The tissue
samples were secured to a custom-made Perspex mount-
ing plate with a thin Perspex frame (Figure 1). X-ray
fluorescence data were acquired at the XFM beamline of
the Australian Synchrotron [15] using the Maia 384 de-
tector [16] and a 18.74 keV X-ray beam. The samples
were mounted approximately 1 mm in front of the de-
tector vertically in-line with the incident X-ray beam.
Energy dispersive spectra were collected by scanning
across the sample at a speed of approximately 6 mm s−1
corresponding to dwell times of 10 ms per 60 um pixel
for slice 7968 and 4.2 ms per 25 um pixel for slice 7970.
Scans of the entire sections took 4 to 16 hours toFigure 1 Heart slice 7970 mounted in front of the Maia detector
at the Australian Synchrotron.acquire. The event data were analyzed using the CSIRO
Dynamic Analysis method [17], which enables quantita-
tive, true-elemental images to be un-mixed from the
generally complex SXRF energy spectrum. Although
XFM is a quantitative technique, in this case the variable
thickness and density of the specimen prevented simple
quantification and so all measurements reported are
relatively scaled only. In sample 7968 there was an inter-
ruption in the scanning from a technical issue which re-
sulted in the loss of some data near the top of the
sample.
Image processing
XFM, R2 and R2* images for sample 7970 were co-
registered at the same resolution (0.5 × 0.5 mm) using
ImageJ (NIH) following resampling of the high reso-
lution XFM image to match the coarser resolution of
the CMR images. To quantitatively compare the XFM
and relaxometry data, 114 circular regions of interest
were overlayed on the left ventricle of the co-registered
XFM, R2 and R2* maps. The R2 and R2* values were plotted
against the XFM intensity and assessed by the Pearson
correlation coefficient.
Iron analysis
The wet weight iron concentrations for the two heart
slices scanned in this study were extracted from ICP-
AES data acquired in a previous study on adjoining
slices from the same heart [8]. The XFM iron maps were
digitally overlayed onto the photographs of each sample
using Photoshop CS4 (Adobe) and the approximate seg-
ments used in Carpenter et al. study [8] were digitally




Photographs of the two heart samples with the corre-
sponding XFM iron, R2 and R2* maps are shown in
Figures 2 and 3. The XFM iron maps of the thick-walled
left ventricle show a strong iron signal along the lateral
wall that extends to the margins of the septum for heart
slice 7968 (Figure 2B), but appears to be truncated along
the anterior margin of heart slice 7970 (Figure 3B). This
band of high iron signal in the epicardium (outer layer)
appears to partially continue into the inferior right ven-
tricle of both samples (Figures 2B, 3B). A strong gradient
in the iron distribution is apparent in the lateral wall of
the left ventricle, which decreases from the outer epicar-
dium to the inner endocardium in both heart sections.
In the interventricular septum the iron is distributed
differently, particularly for slice 7968 where two discon-
tinuous bands of higher iron are apparent (Figure 2B)
within the myocardium layer. In heart slice 7970 there
Figure 2 Heart slice 7968. A) Photo, B) XFM iron map, C) R2 map, D) R2* map. Hot colours represent higher iron signal, R2 or R2* values. Scale bar
1 cm. The dashed line indicates the position of the profile shown in Figure 4. Abbreviations: ANT anterior, INF inferior, LAT lateral, MED medial.
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also within the myocardium (Figure 3B). The XFM iron
signal is, in general, more uniform through the septum.
The right ventricle of both samples shows a discontinu-
ous band of high iron signal within the epicardium layer.
In heart slice 7968 (Figure 2B, black arrows), two oval
regions of low iron signal are evident in the inferior
myocardium and the anteroseptal epicardium. On the
photograph of the sample (Figure 2A, black arrows), theFigure 3 Heart slice 7970. A) Photo, B) XFM iron map, C) R2 map, D) R2*
bar 1 cm. The dashed line indicates the position of the profile shown in Figuranomaly in the inferior myocardium corresponds to a
lighter coloured region of tissue about 3–4 mm across.
In heart slice 7970, there is distinct linear structure that
transects the inferior wall of the heart through the myo-
cardium and endocardium layers that corresponds to a
low iron signal (Figure 3B, black arrow) and a light
coloured feature in the photograph of the sample
(Figure 3A, black arrow). The papillary muscles also ap-
peared to contain moderate to high iron concentrations.map. Hot colours represent higher iron signal, R2 or R2* values. Scale
e 5. Abbreviations: ANT anterior, INF inferior, LAT lateral, MED medial.
Figure 4 Profile across heart slice 7968. (A) XFM signal (black line) and R2 values (blue line), (B) XFM signal (black line) and R2* values (blue line).
The position of the profile is indicated by the dashed line in Figure 2. Abbreviations: M medial, L lateral, LV left ventricle.
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Maps
In general, all of the macroscopic features displayed in
the XFM iron maps are present in the R2 and R2* maps
(Figures 2C,D, 3C,D). In particular, the MR parameterFigure 5 Profile across heart slice 7970. (A) XFM signal (black line) and R
The position of the profile is indicated by the dashed line in Figure 3. Abbrevmaps for both samples have elevated R2 and R2* values
corresponding to the main high iron region in the lateral
epicardium and also show the decreasing gradient from
the outer to inner layer of the lateral left ventricle wall.
More isolated high and low iron regions visible in the2 values (blue line), (B) XFM signal (black line) and R2* values (blue line).
iations: M medial, L lateral, LV left ventricle.
Figure 6 Correlation plots for heart slice 7970. Correlations between XFM iron intensity and R2, R2* (A) and between R2 and R2* (B).
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Profiles across the two samples also show how the larger
scale variations in XFM iron signal are largely matched
by the R2 and R2* profiles (Figures 4 and 5) and some of
the finer scale features evident in the XFM profiles are
also apparent in the R2* profiles in particular.
The relationships between the XFM intensity of slice
7970 and the R2 and R2* data are shown in Figure 6. TheFigure 7 ICP iron concentrations annotated on XFM iron maps
(colour) overlayed on photographs of both heart slices. A)
sample 7968, B) sample 7970. The text figures in white are the iron
concentrations expressed in mg of iron per gram of wet tissue. The
white lines divide the slices into six segments as per the divisions
used in Carpenter et al. [8]. The scale bar is 1 cm.correlation coefficients between XFM and R2 and R2* for
all samples were 0.79 (p < 0.0001) and 0.86 (p < 0.0001),
respectively. The correlation coefficient between R2 and
R2* for all samples was 0.87 (p < 0.0001).
XFM versus elemental iron concentrations
XFM images overlaid onto the photographs of the two
samples are shown in Figure 7 annotated with the iron
concentration data acquired from adjacent slices in a
previous study [8]. Despite the low sampling density of
the elemental analyses, features like the gradient in the
left ventricle are discernable in both samples and in gen-
eral the patterns in the XFM are matched by the varia-
tions in elemental iron concentrations. However, in
some segments the elemental analysis appears to differ
from the XFM intensity and those discrepancies are
most likely to be related to the unevenness of the surface
which could not be made perfectly flat (e.g. inferoseptal
epicardium layer (Figure 7A 0.75 mg/g), anteroseptal
myocardium layer (Figure 7B 0.78 mg/g)). The highest
mean iron concentration of 1.39 mg/g corresponds to
the inferior lateral epicardium in sample 6970 (Figure 7B)
and in general the iron concentration of the epicardium
of both samples exceeds 1 mg/g. Iron concentrations in
the endocardium are typically around 0.5 mg/g for these
samples.
Discussion
To our knowledge this is the first demonstration of
high-resolution synchrotron XFM elemental imaging of
an entire cross section of human heart tissue and the
first study to compare the distribution of XFM iron
maps to quantitative CMR R2 and R2* images. The fast
scanning approach coupled with the Maia detector
allowed the acquisition of XFM iron maps that displayed
the internal iron distribution of the heart in great detail.
Both the R2 and R2* maps displayed a high level of
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in the XFM images and profiles. On co-registered im-
ages, R2 and R2* also showed strong linear correlations
with the XFM signal.
The gradient of decreasing iron from the epicardium to
endocardium we observed in XFM and transverse relax-
ation rates is consistent with the observations of
Carpenter et al. [8] and Ghugre et al. [3]. Compilation of
the iron concentrations from all the samples from this
heart (Additional file 1: Figure S1) also confirm that mean
iron concentrations in the epicardium are significantly
higher compared to the mean iron concentrations in the
myocardium and endocardium. It is not clear why iron ap-
pears to preferentially load into the lateral epicardium of
this patient. Consistent with our case study, an in-vivo
study on Thalassemia Major and Sickle Cell Disease pa-
tients by Ghugre et al. [18] observed elevated R2* values in
the lateral segment of the heart for patients with T2*
greater than 20 ms compared to patients with T2* less than
20 ms. In contrast, the case-study of a 24 year old thalas-
saemic heart by Ghugre et al. [3] measured similar iron
concentrations to our study, but found the outer septal
layer had the highest mean iron concentration, while the
lateral epicardium had the lowest iron concentration in
the left ventricle epicardium layer, as measured by elemen-
tal analysis. Interestingly, the lateral epicardium in that
study had the highest mean R2* and R2, consistent with
our case study. Other studies have reported segmental
variation in R2* for TM patients [19] consistent with the
variations we observed in inferior and anterior segments.
Notwithstanding the results of these workers, observations
from this single case study on the distribution of iron in
heart tissue may not necessarily be generalizable to other
patients with cardiac iron overload.
Although a gradient in XFM iron exists in the septum
of both samples, it is not as strong or consistent as in the
lateral parts of the left ventricle. The images and profiles
suggest that, at least for this case study, the distribution of
iron, R2 and R2* in the septal wall is more uniform overall
with less extremes in the range of iron concentrations,
particularly in the outer layer. The lack of a strong iron
gradient in the septum potentially relates to the absence
of an epicardium layer in the septum, which instead com-
prises a left ventricle endocardium, a mesocardium and a
right ventricle endocardium [20]. However, there is still
discernable structure evident in the septal region of both
hearts (Additional file 2: Figure S2).
Qualitatively and quantitatively, the R2* data agrees
more closely with the XFM iron data than the R2 data.
Apart from the greater sensitivity of R2* to iron concen-
trations, as suggested by the larger regression slope be-
tween R2* and XFM iron, there may be other reasons for
the better agreement of the R2* data. The shorter data
acquisition time of the gradient echo sequence allowed 4signals to be averaged for each gradient echo, compared
to 2 averages for the spin echo data. Hence, the R2* data
may have benefited from higher signal to noise com-
pared to the R2 data. In addition, R2 could potentially to
be more affected by non-iron mediated relaxation mech-
anisms (e.g. hydration) at the iron concentrations ob-
served in this case study.
He et al. [21] investigated in-vivo cardiac R2 and R2* and
observed that the relationship between R2 and R2* is curvi-
linear. Our in-vitro data on fixed cardiac tissue, and that of
Ghugre et al. [3] from fresh cardiac tissue, both show strong
linear relationships between R2 and R2* over a comparable
range in R2* values to He et al. [21]. While differences may
arise comparing in-vivo to in-vitro measurements, another
possible explanation for the discrepancy is the difference in
R2 acquisition sequences. While the multi-echo gradient
echo sequences between all three studies are similar, the R2
measurements in our study and Ghugre et al. [3] used a sin-
gle spin echo acquisition where as He et al. [21] were re-
stricted to a fast multi-echo spin echo acquisition to enable
a short breath-hold acquisition in vivo. A multi-echo spin
echo acquisition will potentially reduce the measured R2
relative to a single spin echo measurement as the multi-
echo refocusing pulses suppress the effects of diffusion. Such
a reduction in R2 may explain the curvilinear relationship
observed by He et al. [21]. Alternatively, the simple fitting of
all echo times we used in this study could, in the presence
of noise, underestimate high R2* values potentially masking
a more curvilinear relationship. In regard to the curvilinear
relationship between R2 and R2* reported in the liver [22],
we note that at relatively low iron concentrations, such as in
this case study (maximum iron concentration 6 mg/g dry
weight) and in Ghugre et al. [3], the relationship between R2
and R2* is essentially linear.
It is difficult to extrapolate the CMR observations
from this in-vitro study to the in-vivo measurement of
cardiac T2*. Our study was performed on formalin fixed
tissue and we reduced the magnetic susceptibility arte-
facts from interfaces found between living tissue and air
or blood by acquiring our R2* data with the sample
immersed in water. In-vitro imaging also does not have
to contend with the motion of the beating heart. The
septal region of the heart is typically used in cardiac T2*
imaging for iron assessment [6,7] as it is bounded by
blood on both sides and hence susceptibility variations
are potentially minimised [3]. Assuming the in-vivo and
in-vitro septum are likely to be the most similar in terms
of their R2* response, our results are consistent with R2*
over the whole septum being a reasonable proxy for
heart iron concentration in this region.
Conclusions
The ability to map elements in large tissue specimens
using a synchrotron source can highlight new insights
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provides a non-destructive technique for comparison
and validation of other imaging modalities. The close
qualitative and quantitative agreement between the syn-
chrotron XFM iron maps and CMR relaxometry maps
indicates that iron is a significant contributor to R2 and
R2* in these ex vivo samples and that R2 and R2* maps of
human heart tissue give information on the spatial dis-
tribution of tissue iron deposits.
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Additional file 1: Figure S1. ICP iron concentrations from all left
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the general decreasing concentration of iron from the epicardium to the
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